Barinthus Biotherapeutics plc (BRNS)
NASDAQ: BRNS · Real-Time Price · USD
0.9225
+0.0313 (3.51%)
Jun 26, 2025, 11:37 AM - Market open

Barinthus Biotherapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2019
Period Ending
Jun '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2019
374914288388-
Upgrade
Market Cap Growth
-57.64%-65.85%62.36%-77.38%--
Upgrade
Enterprise Value
-51-45-5-104162-
Upgrade
Last Close Price
0.891.213.692.3511.11-
Upgrade
PE Ratio
---16.41--
Upgrade
PS Ratio
2.363.25177.441.961445.93-
Upgrade
PB Ratio
0.310.370.760.361.53-
Upgrade
P/TBV Ratio
0.380.450.950.431.86-
Upgrade
EV/Sales Ratio
----605.57-
Upgrade
Debt / Equity Ratio
0.100.090.070.040.03-14.73
Upgrade
Asset Turnover
0.090.080.000.160.000.14
Upgrade
Quick Ratio
8.607.5211.9116.8719.816.12
Upgrade
Current Ratio
9.188.0312.4617.4020.326.27
Upgrade
Return on Equity (ROE)
-45.42%-38.59%-34.15%2.15%-40.98%-420.05%
Upgrade
Return on Assets (ROA)
-18.20%-15.22%-20.73%-0.65%-15.55%-30.07%
Upgrade
Return on Capital (ROIC)
-19.90%-16.68%-22.24%-0.70%-17.00%-36.98%
Upgrade
Earnings Yield
-181.45%-125.68%-51.54%6.09%-13.13%-
Upgrade
FCF Yield
-90.71%-61.39%-39.59%-23.47%-8.70%-
Upgrade
Buyback Yield / Dilution
-2.97%-2.50%-0.57%-47.40%-227.59%-33580.72%
Upgrade
Updated May 7, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q